Automated Author ProfileGao, Yuewen
Guangzhou Medical University
Gao, Yuewen
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 4.0 (sum of 6 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Additional file 2: Table S1. Description of Landmark and Surveillance strategy of each included study. NA: Not applicable. *: The preferred time point as Landmark.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua
Additional file 2: Table S1. Description of Landmark and Surveillance strategy of each included study. NA: Not applicable. *: The preferred time point as Landmark.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua
Additional file 5: Table S2. Information of each included study for meta-analysis between landmark and surveillance strategy. Abbreviations: TP, true positive; FP, false positive; FN, false negative; TN, true negative. *: After excluding patients with small-cell lung cancer, the data for Chaudhuri AA 2017 changed to: landmark: TP = 17, TN = 0, FN = 1, TN = 16; surveillance: TP = 8, TN = 0, FN = 0, TN = 8. ψ: Patients who have been reported in Chaudhuri AA 2017 were excluded. ξ: After using 2 h after surgery as preferred landmark in Peng M 's study, the landmark results changed to: TP = 13, FP = 5, FN = 15, TN = 36.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua
Additional file 5: Table S2. Information of each included study for meta-analysis between landmark and surveillance strategy. Abbreviations: TP, true positive; FP, false positive; FN, false negative; TN, true negative. *: After excluding patients with small-cell lung cancer, the data for Chaudhuri AA 2017 changed to: landmark: TP = 17, TN = 0, FN = 1, TN = 16; surveillance: TP = 8, TN = 0, FN = 0, TN = 8. ψ: Patients who have been reported in Chaudhuri AA 2017 were excluded. ξ: After using 2 h after surgery as preferred landmark in Peng M 's study, the landmark results changed to: TP = 13, FP = 5, FN = 15, TN = 36.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua
Additional file 6: Table S3. Baseline characteristics of patients in included studies.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua
Additional file 6: Table S3. Baseline characteristics of patients in included studies.
Authors
- Zhong, Ran ;
- Gao, Rui ;
- Fu, Wenhai ;
- Li, Caichen ;
- Huo, Zhenyu ;
- Gao, Yuewen ;
- Lu, Yi ;
- Li, Feng ;
- Ge, Fan ;
- Tu, Hengjia ;
- You, Zhixuan ;
- He, Jianxing ;
- Liang, Wenhua